Literature DB >> 17408432

A role for G protein-coupled receptor kinase 2 in mechanical allodynia.

Wendy Kleibeuker1, Annemarie Ledeboer, Niels Eijkelkamp, Linda R Watkins, Steven F Maier, Jitske Zijlstra, Cobi J Heijnen, Annemieke Kavelaars.   

Abstract

Inflammation and nerve injury can both induce mechanical allodynia via mechanisms involving the production of pro-inflammatory cytokines and increased neuronal activity. Many neurotransmitters involved in pain signal via G protein-coupled receptors (GPCRs). GPCR kinase (GRK)2 is a member of the GRK family that regulates agonist-induced desensitization and signalling of GPCRs. Low intracellular GRK2 levels are associated with increased receptor signalling. The aim of this study was to investigate whether mechanical allodynia is associated with decreased spinal cord GRK2 expression and whether reduced GRK2 increases inflammation-induced mechanical allodynia. Mechanical allodynia was induced in rats by chronic constriction injury of the sciatic nerve. After 2 weeks, neuronal GRK2 expression was decreased bilaterally in the superficial layers of the lumbar spinal cord dorsal horn. Moreover, interleukin-1beta significantly reduced GRK2 expression ex vivo in spinal cord slices. To investigate whether reduced GRK2 potentiates inflammation-induced mechanical allodynia, we used GRK2(+/-) animals expressing decreased GRK2. At baseline, the threshold for mechanical stimulation did not differ between GRK2(+/-) and wild-type mice. However, GRK2(+/-) animals were more sensitive to mechanical stimulation than wild-type animals after intraplantar lambda-carrageenan injection. We propose cytokine-induced down-regulation of spinal cord neuronal GRK2 expression as a novel mechanism that contributes to increased neuronal signalling in mechanical allodynia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408432     DOI: 10.1111/j.1460-9568.2007.05423.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

Review 1.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 2.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

3.  Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1.

Authors:  Pooja Singhmar; XiaoJiao Huo; Niels Eijkelkamp; Susana Rojo Berciano; Faiza Baameur; Fang C Mei; Yingmin Zhu; Xiaodong Cheng; David Hawke; Federico Mayor; Cristina Murga; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 4.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

5.  Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals.

Authors:  Simona Daniele; Letizia Natali; Chiara Giacomelli; Pietro Campiglia; Ettore Novellino; Claudia Martini; Maria Letizia Trincavelli
Journal:  Mol Cell Biol       Date:  2017-03-31       Impact factor: 4.272

6.  GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain.

Authors:  Niels Eijkelkamp; Cobi J Heijnen; Hanneke L D M Willemen; Ronald Deumens; Elbert A J Joosten; Wendy Kleibeuker; Ilona J M den Hartog; Cindy T J van Velthoven; Cora Nijboer; Mohammed A Nassar; Gerald W Dorn; John N Wood; Annemieke Kavelaars
Journal:  J Neurosci       Date:  2010-02-10       Impact factor: 6.167

7.  Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.

Authors:  Dioneia Araldi; Luiz F Ferrari; Jon D Levine
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 8.  Pathological pain and the neuroimmune interface.

Authors:  Peter M Grace; Mark R Hutchinson; Steven F Maier; Linda R Watkins
Journal:  Nat Rev Immunol       Date:  2014-02-28       Impact factor: 53.106

9.  Human sensory neuron-specific Mas-related G protein-coupled receptors-X1 sensitize and directly activate transient receptor potential cation channel V1 via distinct signaling pathways.

Authors:  Hans Jürgen Solinski; Susanna Zierler; Thomas Gudermann; Andreas Breit
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

10.  Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.

Authors:  Huijing Wang; Cobi J Heijnen; Cindy T J van Velthoven; Hanneke L D M Willemen; Yoshihiro Ishikawa; Xinna Zhang; Anil K Sood; Anne Vroon; Niels Eijkelkamp; Annemieke Kavelaars
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.